Oxygen-boosting drug aims to make radiation more effective against deadly brain cancer

NCT ID NCT03862430

First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 24 times

Summary

This study tests whether adding an experimental drug called NanO2 to standard radiation and chemotherapy can help people with newly diagnosed glioblastoma, an aggressive brain cancer. The drug is designed to deliver more oxygen to the tumor, which may make radiation work better. About 87 adults with this diagnosis are participating to see if the combination improves how long the cancer stays under control.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA MULTIFORME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Atlantic Health System

    Summit, New Jersey, 07901, United States

  • Center for Neurosciences

    Tucson, Arizona, 85718, United States

  • Duke University Medical Center

    Durham, North Carolina, 27710, United States

  • Inova Schar Cancer Institute

    Fairfax, Virginia, 22031, United States

  • Ochsner Clinic Foundation

    New Orleans, Louisiana, 70121, United States

  • Providence St. John's Cancer Institute

    Santa Monica, California, 90404, United States

  • Saint Luke's Cancer Institute

    Kansas City, Missouri, 64111, United States

  • St. Francis Medical Center, OSF Healthcare

    Peoria, Illinois, 61637, United States

  • UC Irvine Health- Chao Family Comprehensive Cancer Center

    Orange, California, 92868, United States

  • University Hospitals Seidman Cancer Center

    Cleveland, Ohio, 44106, United States

  • University of Arizona

    Tucson, Arizona, 85719, United States

  • Yale Cancer Center

    New Haven, Connecticut, 06520, United States

Conditions

Explore the condition pages connected to this study.